Clinical Trials Directory

Trials / Completed

CompletedNCT03918031

Personalized Feedback for Distress Intolerant Smokers

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
121 (actual)
Sponsor
University of Houston · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This project will develop and refine a computer-delivered integrated Personalized Feedback Intervention (PFI) that directly addresses smoking and distress tolerance. The PFI will focus on feedback about smoking behavior, distress tolerance, and adaptive coping strategies.

Detailed description

The primary goal of the research study is to investigate the efficacy of a brief, personalized computer-delivered transdiagnostic intervention (PFI) that addresses smoking and distress tolerance to reduce smoking, increase quit attempts, reduce perceived barriers to cessation, increase distress tolerance, reduce anxiety/depressive symptoms, and increase adaptive coping skills compared to a personalized feedback on smoking only control. To address this aim, the investigators will implement a randomized controlled trial that will employ a longitudinal experimental design and involve four stages: (a) phone-screener (pre-screener); (b) baseline appointment consisting of a pre-intervention assessment (eligibility), random assignment to a one-session computer-delivered intervention (Active PFI versus Control PFI with no personalized feedback on distress tolerance), and a post-intervention assessment; (c) 2-week follow-up; (d) 1-month follow-up. Assessments will include a multi-method approach, including biological, behavioral, and self-report methods.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPFI for Smoking & Distress TolerancePersonalized Feedback Intervention for smoking and distress tolerance.
BEHAVIORALPFI for Smoking OnlyPersonalized Feedback Intervention for smoking only (no distress tolerance component)

Timeline

Start date
2019-07-15
Primary completion
2021-10-24
Completion
2021-10-24
First posted
2019-04-17
Last updated
2024-11-15
Results posted
2024-11-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03918031. Inclusion in this directory is not an endorsement.